AstraZeneca Unveils Data Behind New Win For Blockbuster Drug

Bookmark
(Bloomberg) -- AstraZeneca Plc’s blockbuster drug Tagrisso cut the risk of lung cancer death or relapse by four-fifths over three years, according to detailed results from a study that raises survi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.